The head of Claude Code hasn’t ‘written a line of code by hand’ in 8 months

The man who built the tool that’s rewriting how software gets made hasn’t touched a keyboard to write code in the better part ...
pharmaphorum

Change at the top of Recursion as co-founder leaves CEO role

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The Hacker News

Six Proto6 Vulnerabilities in protobuf.js Expose Node.js Apps to RCE and DoS

Six Proto6 flaws in protobuf.js enable RCE and DoS attacks; patched in versions 7.5.6 and 8.0.2 to protect Node.js services.
Morningstar

Recursion Pharmaceuticals Inc Class A RXRX

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.